Metropolitan Life Insurance Company (MetLife)’s Ovintiv OVV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-16,337
Closed -$883K 2417
2022
Q1
$883K Sell
16,337
-50,842
-76% -$2.19M 0.03% 446
2021
Q4
$2.26M Sell
67,179
-1,375
-2% -$49.1K 0.03% 463
2021
Q3
$2.25M Sell
68,554
-2,537
-4% -$70.1K 0.03% 453
2021
Q2
$2.24M Buy
71,091
+169
+0.2% +$4.54K 0.03% 470
2021
Q1
$1.69M Sell
70,922
-3,343
-5% -$71.5K 0.03% 606
2020
Q4
$1.07M Sell
74,265
-5,421
-7% -$63.5K 0.02% 834
2020
Q3
$650K Sell
79,686
-1,298
-2% -$13.4K 0.01% 1024
2020
Q2
$773K Buy
+80,984
New +$565K 0.01% 897

Other funds holding OVV

Metropolitan Life Insurance Company (MetLife)'s OVV Position: Q2 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Ovintiv (OVV) in Q2 2022, closing a stake of 16,337 shares — an estimated $883K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in OVV in Q2 2020 and held it in 8 quarters. The position peaked at $2.26M in Q4 2021. 435 funds tracked by Wall St. Rank hold OVV as of Q2 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Ovintiv position as of Q2 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 16,337 Ovintiv shares in Q2 2022, an estimated $883K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Ovintiv in Q2 2020 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Ovintiv position peaked at $2.26M in Q4 2021.
  • 435 funds tracked by Wall St. Rank held Ovintiv as of Q2 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2022, filed 11 Aug 2022.